抗真菌乙素:历史发现,综合性结构-活性关系,耐药性机制和未来发展
Mylène Lang1, Victoria Susan2, Lucie Brendel2
1Chemobiology and Pharmacognosy for Health (CPS) Team, Strasbourg Institute for Drug Discovery and Development (ITI IMS), Laboratory of Therapeutic Innovation (LIT), UMR 7200 CNRS/Unistra, Faculty of Pharmacy, 74, route du Rhin, Illkirch, 67400, France; University of Strasbourg Institute for Advanced Studies (USIAS), 67000, Strasbourg, France.
European journal of medicinal chemistry
|September 5, 2025
概括
通过向真菌细胞壁的合成,埃奇诺坎丁 (ECs) 提供了一种针对侵入性真菌感染的新机制. 药物化学对于开发新的抗真菌药物来克服新出现的耐药性挑战至关重要.
科学领域:
- 医学化学
- 发现抗真菌药物
- 化学生物学
背景情况:
- 在2000年代之前,有限的抗真菌选择导致了现有药物的耐药性问题.
- 侵袭性真菌感染带来了重大治疗挑战.
- 埃奇诺坎丁 (ECs) 作为一种具有新奇作用机制的新类出现.
研究的目的:
- 审查类药物的发现,发展和作用机制.
- 为EC提供结构-活动 (SAR) 和结构-属性关系 (SPR) 的综合分析.
- 讨论抗真菌耐药性,并强调药物化学在开发新抗真菌剂中的作用.
主要方法:
- 史料回顾素的发现和发展.
- 通过结构和化学生物学方法分析乙素的作用机制.
- 关于SAR和SPR,耐药性数据和未来药物候选物的综合文献审查.
主要成果:
- 乙甘抑制β- 1,3) - D- 葡萄糖合成酶,这对于真菌细胞壁的完整性至关重要.
- 具有良好的药物动力学特性,包括低肝代谢和缓慢排泄,减少药物相互作用.
- 结构 - 活性和结构 - 特性关系为echinocandin的有效性和新药设计的潜力提供了洞察力.
结论:
- 在治疗侵袭性真菌感染方面,
- 了解SAR和SPR是克服新兴抵抗机制的关键.
- 药物化学在扩大抗真菌治疗武器库中发挥着至关重要的作用.
相关概念视频
Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
Overview of Fungi
189
Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
189
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K


